Business Trends

Oct 16, 2017
By BioPharm International Editors
The new center will serve as a regional hub where scientists and engineers can work with customers for biological development.
Oct 11, 2017
By BioPharm International Editors
The company is considering options for a full or partial separation of its Consumer Healthcare business, either through a spin-off, sale, or other transaction.
Oct 01, 2017
BioPharm International
Reeling from financial and tropical storms, Puerto Rico needs stable industry to aid its recovery.
Sep 27, 2017
By BioPharm International Editors
Fresenius Kabi broke ground on a previously announced $250 million expansion of its Melrose Park, IL, manufacturing facility.
Sep 26, 2017
By BioPharm International Editors
UPS has revealed a new system to improve drug supply chain security, in compliance with the Drug Supply Chain Security Act (DSCSA).
Sep 19, 2017
By BioPharm International Editors
The acquisition adds to Catalent’s capabilities in biologics development, analytical services, manufacturing, and finished product supply.
Sep 15, 2017
BioPharm International
Cell-based therapies are moving medical treatments forward, but intellectual property uncertainties may delay progress.
Sep 12, 2017
By BioPharm International Editors
Alexion’s restructuring will reduce its global workforce by 20%, including closing a manufacturing facility in Rhode Island.
Sep 01, 2017
BioPharm International
Faced with divisive political and social issues, Congress must find a way to reach consensus.
Jul 01, 2017
BioPharm International
How has the bio/pharmaceutical contract manufacturing industry evolved and changed over the years and what does the future hold?
native1_300x100
lorem ipsum